BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 9043756)

  • 1. Tubal ligation and the risk of ovarian carcinoma.
    Cornelison TL; Natarajan N; Piver MS; Mettlin CJ
    Cancer Detect Prev; 1997; 21(1):1-6. PubMed ID: 9043756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of tubal ligation on the incidence of epithelial cancer of the ovary.
    Koch M; Starreveld AA; Hill GB; Jenkins H
    Cancer Detect Prev; 1984; 7(4):241-5. PubMed ID: 6488215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubal ligation and risk of breast cancer.
    Brinton LA; Gammon MD; Coates RJ; Hoover RN
    Br J Cancer; 2000 May; 82(9):1600-4. PubMed ID: 10789731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.
    McGuire V; Felberg A; Mills M; Ostrow KL; DiCioccio R; John EM; West DW; Whittemore AS
    Am J Epidemiol; 2004 Oct; 160(7):613-8. PubMed ID: 15383404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
    Rosenblatt KA; Thomas DB
    Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):933-5. PubMed ID: 8922304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
    Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
    Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
    Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
    Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of pregnancy and the risk of epithelial ovarian cancer.
    Whiteman DC; Siskind V; Purdie DM; Green AC
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubal ligation and survival of ovarian cancer patients.
    Zhang M; Holman CD
    J Obstet Gynaecol Res; 2012 Jan; 38(1):40-7. PubMed ID: 22070411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthropometry and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Ness RB; Allen GO
    Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubal sterilization and risk of cancer of the endometrium.
    Lacey JV; Brinton LA; Mortel R; Berman ML; Wilbanks GD; Twiggs LB; Barrett RJ
    Gynecol Oncol; 2000 Dec; 79(3):482-4. PubMed ID: 11104624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer.
    Bushley AW; Ferrell R; McDuffie K; Terada KY; Carney ME; Thompson PJ; Wilkens LR; Tung KH; Ness RB; Goodman MT
    Gynecol Oncol; 2004 Dec; 95(3):672-9. PubMed ID: 15581980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
    Risch HA; Howe GR
    Cancer Epidemiol Biomarkers Prev; 1995; 4(5):447-51. PubMed ID: 7549798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marital and reproductive experience in a community-wide epidemiological study of breast cancer.
    Lilienfeld AM; Coombs J; Bross ID; Chamberlain A
    Johns Hopkins Med J; 1975 Apr; 136(4):157-62. PubMed ID: 1123861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based case-control study of ovarian cancer in Shanghai.
    Shu XO; Brinton LA; Gao YT; Yuan JM
    Cancer Res; 1989 Jul; 49(13):3670-4. PubMed ID: 2731180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Allen GO; Ness RB
    Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.